# Victor Cohen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/victor-cohen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,420 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 32 |
| i10-index | 60 |
| Last Known Institution | Jewish General Hospital |
| OpenAlex ID | https://openalex.org/A5112820949 |
| Works | 135 |

## Researcher papers

- [Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab](https://scholariq.org/papers/assessment-of-echocardiography-and-biomarkers-for-the-extended-prediction-of/)
- [Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients](https://scholariq.org/papers/early-detection-and-prediction-of-cardiotoxicity-in-chemotherapy-treated/)
- [Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab](https://scholariq.org/papers/early-increases-in-multiple-biomarkers-predict-subsequent-cardiotoxicity-in/)
- [Systemic cancer therapy: achievements and challenges that lie ahead](https://scholariq.org/papers/systemic-cancer-therapy-achievements-and-challenges-that-lie-ahead/)
- [Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)](https://scholariq.org/papers/differential-regulation-of-pd-l1-expression-by-immune-and-tumor-cells-in-nsclc/)
- [Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy.](https://scholariq.org/papers/methylenetetrahydrofolate-reductase-polymorphism-in-advanced-colorectal-cancer-a/)
- [Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab](https://scholariq.org/papers/longitudinal-changes-in-multiple-biomarkers-are-associated-with-cardiotoxicity/)
- [Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial](https://scholariq.org/papers/intravenous-subdissociative-dose-ketamine-versus-morphine-for-analgesia-in-the/)
- [Effect of clinical pharmacists on care in the emergency department: A systematic review](https://scholariq.org/papers/effect-of-clinical-pharmacists-on-care-in-the-emergency-department-a-systematic/)
- [Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial](https://scholariq.org/papers/dacomitinib-compared-with-placebo-in-pretreated-patients-with-advanced-or/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Jewish General Hospital](https://scholariq.org/institutions/jewish-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.